Memorial Sloan Kettering Cancer Center

MSK Kids Study: Children with Cancer are Not at a Higher Risk for COVID-19 Infection or Morbidity

MSK Kids researchers publish report of screening and testing for COVID-19 in pediatric cancer patients in New York City

Newswise — May 13, 2020, NEW YORK CITY — Researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) found that children with cancer are not at a higher risk of being affected by COVID-19. This new research led by Andrew Kung, MD, PhD, Chair of MSK Kids and his colleagues was published today in JAMA Oncology.  MSK Kids is one of the largest pediatric cancer programs in the United States with a patient population that includes children, adolescents and young adults with cancer and a small proportion with non-oncological diseases such as bone marrow failure and immunodeficiencies.

Bottom Line: Pediatric cancer patients are no more vulnerable than other children to COVID-19 infection or morbidity resulting from COVID-19. Of all children with cancer infected with COVID-19, 95 percent had mild symptoms and did not require hospitalization. MSK Kids clinicians also tested asymptomatic children with cancer finding only a 2.5 percent rate of positivity compared to nearly 15 percent in their adult caregivers. Only half of the children with COVID-19 positive caregivers were themselves also COVID-19 positive. The researchers also found a very significant sex skewing with the vast majority of COVID-19 infections occurring in males. Together, these results suggest that children with cancer are not more susceptible than other children to infection or symptoms resulting from COVID-19, and that children are not an unrecognized reservoir of asymptomatic COVID-19 infection.

Methods and Findings: From March 10 through April 12, 2020, MSK Kids researchers instituted a screening and testing plan to mitigate risk associated with infection with COVID-19. MSK Kids patients were screened for exposure to contacts with known COVID-19 infection or for the presence of symptoms of COVID-19 illness at MSK.  Researches performed COVID-19 testing on pediatric patients and their adult caregivers.  Of the 178 unique pediatric cancer patients tested, the rate of positivity for COVID-19 was 29.3 percent in children with symptoms, but only 2.5 percent in asymptomatic children. Of the 20 patients who tested positive for COVID-19, only 3 were female.

Only one patient with COVID-19 illness required non-critical care hospitalization for COVID-19 associated symptoms. All other pediatric patients had mild disease symptoms and were managed at home. Of the 74 adult caregivers tested, 13 caregivers of 10 patients were found to be positive for COVID-19, including a 14.7 percent rate of COVID-19 infection in asymptomatic caregivers.  Only half of the patients with COVID-19 positive caregivers were themselves also COVID-19 positive, suggesting low infectivity in children despite close household contacts.

While the overall numbers in the study are small, the data confirms that the overall morbidity of COVID-19 illness in pediatric cancer patients is low with only 5 percent requiring hospitalization for symptoms of COVID-19 infection; and that the rate of COVID-19 infection among asymptomatic pediatric patients is very low.

Journal: “COVID-19 in Children with Cancer in New York City” was published in the May 13, 2020 edition of JAMA Oncology.

Author Commentary: “We are encouraged by these latest findings that kids with cancer are not more endangered by COVID-19 and their symptoms are mild like in healthy children,” said Andrew Kung, MD, PhD, and corresponding author on the study. “These findings allow us to continue lifesaving cancer-directed therapy with standard precautions and safeguards but without heightened concern about adverse effects from COVID-19 infection.”

###

About Memorial Sloan Kettering (MSK):

As the world’s oldest and largest private cancer center, Memorial Sloan Kettering has devoted more than 135 years to exceptional patient care, influential educational programs, and innovative research to discover more effective strategies to prevent, control and, ultimately, cure cancer. MSK is home to more than 20,000 physicians, scientists, nurses, and staff united by a relentless dedication to conquering cancer. Today, we are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, with state-of-the-art science and technology supporting groundbreaking clinical studies, personalized treatment, and compassionate care for our patients. We also train the next generation of clinical and scientific leaders in oncology through our continually evolving educational programs, here and around the world. Year after year, we are ranked among the top two cancer hospitals in the country, consistently recognized for our expertise in adult and pediatric oncology specialties. www.mskcc.org.

 

 




Filters close

Showing results

1120 of 2776
Released: 3-Aug-2020 9:00 AM EDT
Neutrolis Announces Development Of First-In-Class Treatment Targeting Neutrophil Extracellular Traps (NETs) For Patients With Severe COVID-19
Neutrolis

Novel Chromatinase™ platform could rapidly and systemically removes NETs associated with exacerbation of COVID-19

Released: 3-Aug-2020 8:55 AM EDT
American College of Radiology to Provide Image Coordination for National COVID-19 Observational Study
American College of Radiology (ACR)

The American College of Radiology® (ACR®) Center for Research and Innovation™ (CRI) will serve as the imaging coordination center for the multicenter COVID-19 Observational Study (CORAL) led by Dr. Catherine "Terri" L. Hough of the Oregon Health & Science University. The CORAL Study is part of the Prevention & Early Treatment of Acute Lung Injury (PETAL) Network, a consortium of academic and affiliated hospitals across the United States – funded by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health – to conduct clinical trials in patients with or at risk for critical illness, including acute respiratory distress syndrome.

Released: 3-Aug-2020 8:35 AM EDT
Evaluating the effectiveness of travel bans
International Institute for Applied Systems Analysis

A new study sheds light on how COVID-19 spreads regionally and between countries, as well as on how effective governmental measures to curb the spread of the pandemic have been to date.

Newswise: Engineers developing no-touch, mail-in, fast-scan test for COVID-19, other outbreaks
Released: 3-Aug-2020 8:00 AM EDT
Engineers developing no-touch, mail-in, fast-scan test for COVID-19, other outbreaks
Iowa State University

Engineers are developing a no-touch, mail-in, fast-scan diagnostic sensing system that could be used to quickly test for COVID-19 or other outbreaks. The system would also produce a real-time outbreak map with demographic details.

Newswise: Atrium Health Tele-ICU Evolves to Meet COVID-19 Challenges
30-Jul-2020 1:55 PM EDT
Atrium Health Tele-ICU Evolves to Meet COVID-19 Challenges
American Association of Critical-Care Nurses (AACN)

Atrium Health’s tele-ICU quickly adjusted its patient-centered focus to include supporting and protecting bedside nurses caring for patients in isolation, as part of the system’s planning and preparations for the pandemic.

Released: 31-Jul-2020 5:05 PM EDT
Looking up to the Joneses: Consequences of the perceptions of white wealth
Society for Personality and Social Psychology

Before the era of COVID-19, research suggested that premature deaths among white Americans were rising. Even before the era of COVID-19, these findings were surprising.

Newswise: 238996_web.jpg
Released: 31-Jul-2020 4:55 PM EDT
Pooling strategy in the wake of the COVID-19 pandemic: A solution for mass population screening of SARS-CoV-2
Elsevier

In a report in the Journal of Molecular Diagnostics, published by Elsevier, researchers at Augusta University and PerkinElmer Genomics describe a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples.

Released: 31-Jul-2020 4:40 PM EDT
No racial disparities seen in response to remdesivir treatment of COVID-19
University of Chicago Medical Center

A new analysis by University of Chicago Medicine faculty, staff and collaborators around the world found remdesivir appears to be equally beneficial to patients regardless of race, supporting the need for early intervention and aggressive care for all patients in the fight against COVID-19.

Released: 31-Jul-2020 3:50 PM EDT
SARS-CoV-2 screening strategies for safe reopening of college campuses
JAMA - Journal of the American Medical Association

What The Study Did: This study defines the screening performance standards for SARS-CoV-2 tests that would permit the safe return of students to U.S. residential college campuses this fall. Authors: A. David Paltiel, Ph.D., of the Yale School of Public Health in New Haven, Connecticut, is the corresponding author. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2020.16818) Editor's Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. ### Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/1

access_time Embargo lifts in 2 days
Embargo will expire: 4-Aug-2020 11:00 AM EDT Released to reporters: 31-Jul-2020 3:15 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

1120 of 2776

close
0.88354